ARTICLE | Clinical News
Avodart dutasteride: Phase IV data
February 6, 2012 8:00 AM UTC
GlaxoSmithKline markets Avodart in over 90 countries to treat symptoms of benign prostatic hyperplasia (BPH) in men with an enlarged prostate. Last year, the pharma said it would no longer pursue appr...